Key clinical point: Women with FXI deficiency were found to be at risk for obstetric and gynecologic hemorrhage.
Major finding: Bleeding occurred in 27.4% of women with FXI deficiency, with the majority of events being a single episode.
Study details: A retrospective analysis of 95 females with FXI deficiency.
Disclosures: The study was funded by Fundación Española de Trombosis y Hemostasia and Sociedad Española de Hematología y Hemoterapia in Spain. The authors reported having no conflicts of interest.
Bravo-Perez C et al. Med Clin (Barc). 2019 Mar 26. doi: 10.1016/j.medcli.2019.01.029.